If GJA9‐MYCBP and PVT1 demonstrate presence in cases where established biomarkers fall short, it suggests a distinctive and possibly more sensitive role for these lncRNAs in detecting ALL. This evidence concerns the gene MYCBP and acute lymphoblastic leukemia.